PBMs readying their defenses against pharmaceutical companies
Pharmacy benefits managers lay out lobby plan in strategy memo as the middlemen are now taking it from all sides.
Robert Langreth
Death sentence no longer a given for patients with skin cancer
Nathan Schwegman was just 25 when his doctor told him he had a 3% chance of surviving the melanoma that had spread into his lungs and spine, soon leaving him in so much pain he could hardly move.
Human immune-boosting cancer drugs seen extending lives
Merck & Co., Bristol-Myers Squibb Co. and Roche Holding AG have opened a new front against cancer with the next generation of experimental drugs that use the human immune system to seek and destroy tumor cells.